Quarterly compliance certificate under SEBI Regulation 74(5) for Sep 2026

Compliance View source PDF Explain this filing

THYROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.2%Reaction day

₹530.00

prior close

₹532.40

announcement price

After-mkt

timing

Nifty Microcap 250market-0.2%-3.0% vs market

Healthcare Service Provider peers, median of 27sector+0.0%-3.2% vs sector

On the reaction day the stock moved 3.0 pts less than Nifty Microcap 250 and 3.2 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.1

10m

-1.9

15m

-1.7

30m

-2.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.2-0.2-3.0+0.0-3.2

Next day

-5.7-3.0-2.7-2.0-3.7

-5.9-2.7-3.1+0.6-6.5

-3.0-1.9-1.1+0.1-3.1

-5.9-1.7-4.1-2.5-3.3

-6.9-1.0-5.9+0.3-7.2

-8.1-2.0-6.1-0.7-7.4

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Thyrocare Technologies submitted a quarterly compliance certificate to NSE and BSE under SEBI Regulation 74(5). Its Registrar MUFG Intime India confirmed the regulation does not apply as the full shareholding is held in demat form, and no rematerialisation requests were received in the quarter ended September 30, 2026.

Likely market impact

Routine regulatory compliance filing; no impact on business, financials, or shareholders.